Sedative tested as lifeline for deadly shock patients
NCT ID NCT03953677
Summary
This study tested whether adding a sedative drug called dexmedetomidine could help patients with severe septic shock, a life-threatening condition where blood pressure drops dangerously low and doesn't respond to standard medications. The goal was to see if this drug could improve the body's response to blood pressure-raising treatments. The trial was small and ended early, but aimed to gather evidence for future larger studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chu Dijon Bourgogne
Dijon, 21000, France
Conditions
Explore the condition pages connected to this study.